INSUBCONTINENT EXCLUSIVE:
Casper, joined by One Medical, carried over $870 million of private capital, venture and otherwise, across the finish line.Even though each
IPO featured an unprofitable tech-enabled business that had posted sub-30% growth and gross margins under 50% (far more, in the case of One
Medical), they wound up miles apart in terms of their market reception and resulting valuation, measured in revenue multiples terms.So what
can we learn from the two IPOs as we look ahead to other unicorn debuts in 2020? A great number of things that help set the stage for the
The company, today worth $3.13 billion, is trading at 11.3x times the top end of its 2019 revenue projections (the company has yet to close
the books on its Q4 accounting).
